Abstract:Background: The Von Hippel-Lindau (VHL) gene is a tumor-suppressor gene. Recent studies have shown that low expression of VHL has a close relationship with tumor formation, progression, and prognosis. Hypoxia-inducible factor (HIF)-1 alpha is a transcription factor, which exists universally in mammals including humans under states of hypoxia. Some studies have also shown that expression of HIF-1 alpha closely correlates with tumor progression, angiogenesis, metastasis, and invasion. This molecule is also an important cytokine, which may be used to evaluate the prognosis of some malignant tumors. In this study, we studied the expression of VHL and HIF-1 alpha and evaluated their clinicopathologic significance and relationship in benign and malignant lesions of the gallbladder.Methods: EnVision immunohistochemistry was used for detecting the expression level of VHL and HIF-1 alpha in routinely paraffin-embedded sections from specimens of gallbladder adenocarcinoma (n = 108), peritumoral tissues (n = 46), adenomatous polyps (n = 15), and chronic cholecystitis (n = 35).Results: The frequency of positive VHL expression was significantly lower in adenocarcinoma of gallbladder (48.1%) than that in peritumoral tissues (80.4%), adenomatous polyps (80.0%), and chronic cholecystitis (88.6%) (P < 0.05 or P < 0.01). In contrast, the positive HIF-1 alpha expression was significantly higher in adenocarcinoma (53.7%) than that in peritumoral tissues (34.8%), adenomatous polyps (26.7%), and chronic cholecystitis (14.3%) (P < 0.05 or P < 0.01). The benign lesions with positive VHL and/or negative HIF-1 alpha expression showed atypical hyperplasia in gallbladder epithelium. The positive expression of VHL and negative expression of HIF-1 alpha were significantly associated with differentiation, tumor mass, lymph node metastasis, and invasion of adenocarcinoma (P < 0.05 or P < 0.01). The highly inconsistent expression of VHL and HIF-1 alpha in gallbladder adenocarcinoma was found P < 0.01). Univariate Kaplan-Meier analysis showed that elevated expression of VHL (P = 0.023) or lowered expression of HIF-1 alpha (P = 0.020) was closely associated with decreased overall survival. Multivariate Cox regression analysis showed that positive expression of VHL (P = 0.013) and/or negative expression of HIF-1 alpha (P = 0.005) was an independent poor-prognostic predictor in gallbladder adenocarcinoma.Conclusions: The lowered expression of HIF-1 alpha and elevated expression of VHL in gallbladder adenocarcinoma are important markers for the progression, clinical biological behavior, and prognosis. Measurement of VHL and HIF-1 alpha expression could be a tool for early detection of gallbladder cancer in benign lesions and in population screening. The highly inconsistent expression of VHL and HIF-1 alpha in gallbladder may require further study to see whether they are intrinsically related.

Immunohistochemical detection of the von Hippel-Lindau gene product (pVHL) in human tissues and tumors: a useful marker for metastatic renal cell carcinoma and clear cell carcinoma of the ovary and uterus.

Immunohistochemical Detection Of The Von Hippell-Lindau Gene Product (Pvhl) In Human Tissues And Tumors

A Clinical Analysis of Multilocular Cystic Renal Cell Carcinoma and Its Correlation with Mutation of the Von Hippel-Lindau Gene

Diagnostic value and significance of pVHL in ovarian clear cell carcinoma

Aberrant Expression of the Von Hippel-Lindau Gene in Human Endometrial Hyperplasia and Endometrial Carcinoma.

[Frequent Somatic Mutations of the Von Hippel-Lindau (VHL) Tumor Suppressor Gene and Its Meaning in Sporadic Human Renal Clear Cell Carcinoma].

[Frequent Somatic Mutations of the Von Hippel-Lindau Tumor Suppressor Gene in Primary Sporadic Human Renal Clear Cell Carcinomas].

Distinctive Clinicopathological Features of Von Hippel-Lindau-associated Hereditary Renal Cell Carcinoma: A Single-Institution Study

VHL gene expression and its prognostic value in clear cell renal cell carcinoma

[Analysis of Biallelic Inactivation of the Von Hippel-Lindau Tumor Suppressor Gene VHL in Patients of Renal Cell Carcinoma Patient].

Mutation of Von Hippel-Lindau Tumor Suppressor Gene in Sporadic Clear Renal Cell Carcinoma and Its Significance

Abnormality of VHL Gene and VEGF Expression in Primary Renal Cell Carcinoma

VHL Loss Predicts Response to Aurora Kinase A Inhibitor in Renal Cell Carcinoma Cells.

Diagnosis and Treatment of Renal Cell Carcinoma Associated with Von Hippel-Lindau Disease

Differential Expression of PD-L1 Between Sporadic and VHL-Associated Hereditary Clear-Cell Renal Cell Carcinoma and Its Correlation with Clinicopathological Features.

High VHL Expression Reverses Warburg Phenotype and Enhances Immunogenicity in Kidney Tumor Cells

[Somatic Mutations of VHL Gene and HIF-1alpha Expression in Primary Renal Clear Cell Carcinomas].

The Mutation and Abnormal Methylation of VHL Tumor-Suppressor Gene in Primary Renal Cell Carcinoma

Clinicopathological characteristics of renal cell carcinoma associated with von Hippel-Lindau disease

Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder

Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-with implication of their roles in early tumorigenesis.